Transparency Market Research (TMR) expects the global dental practice management software market to touch a US$4.3 bn by the end of 2025 while posting an 11.0% CAGR during the forecast period 2017-2025. In 2016, the global dental practice management software market earned a US$1.6 bn.

Large Number of People Suffering from Periodontal Diseases Increased Demand for Dental Clinics

The demand for dental practice management software is largely seen in dental clinics. This is mainly because of increasing number of patients looking for dental services.  Large number of specialized dental services and adoption of digital platforms for marketing of dental practices are some of the other factors responsible for the growth of this market. Furthermore, large number of cases of patient who need prosthetic rehabilitation, periodontal diseases, and growing incidence of dental carries has increased the number of patients visiting dental clinics. High digitalization budgets and growing number of multinational hospital chains is expected to drive the demand for hospitals offering advance and better dental services.

Request to View Sample of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11357

Dental Practice Management Software to Attain High Growth through Value Added Features

The demand for dental practice management software has wide range of features and benefits including treatment planning, patient scheduling, electronic prescriptions, billing, insurance claims, clinical charting, and business analytical solutions for hospitals and dentists. It helps in hospitals and dentists to streamline their daily workflow and manage their practice efficiently. Moreover, various players in the market are offering the dental practice management software with other features such as online appointment scheduling, accounting feature, and patient communication, and imaging modules that removes the need for the separate software for each tasks. These features assists in reducing operating cost and improves overall effectiveness of the dental practices. The value added features that helps in streamlining day-to-day workflow and increase the revenue of the practices.

Download PDF Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11357

Advanced technology has helped in improving the ways healthcare and management was carried out. Talking about the dental practice management software is one of the most used software to treat large number of patients across the globe. Due to large volume of data, front office staff and dental professionals are making efforts to find a solution that will help them to store, record, and improve access to patient information. This management software has improved operational efficiency of dental practices as it acts as both administrative and clinical tool.

Focus on Developing Software Integration Facilities to Assist Market Growth

Several companies operating in the dental practice management software market are developing software integration facilities in their system. This will further help in effective integration of the DPMS with dental imaging tools including digital radio-graphs, intra-oral cameras, awareness programs, and patient education. The main motive behind integrating these tools is to save the operational time of the dentist and to improve dentist practice management performance. Some of the key companies operating in the dental practice management software are Open Dental Software, Ace Dental, Web.com Group, Inc., Planet DDS, Inc., and MOGO, Inc.

In terms of revenue, the global CT scanners market is estimated to be at US$6,429.8 mn by 2022, considerably up from its evaluated worth of US$4,834.1 mn by 2017. The growth of the global CT scanners market is projected to increase at a CAGR of 5.9% during the forecast period of 2017 to 2022. This growth is attributable to gaining traction from a number of factors such as increasing preference of the patients for minimally invasive diagnostic procedures, recent product improvements including the advent of portable CT scanners, improve healthcare infrastructure in various emerging economies, and rising geriatric population.

The healthcare industry has witnessing prosperous and substantially dependent on product innovation. Growth factor of CT scanners market is similar to the healthcare industry, which consist incredible potential for development and revenue generation for key players globally, especially for those vendors who can stay in-sync with the latest technologies. These advancement are driving growth of the global CT scanners market.

CT scan is a mature imaging technique that has witnessed substantial modifications and improvements over the past few years. Technological advancements have reduced the dose of radiation without hampering the quality of image. Such technological advancements coupled with the procedural benefits of CT scan over other imaging modalities such as MRI and X-ray are boosting adoption of CT scanners across numerous applications, which in turn is driving growth of the global CT scanners market.

Request PDF Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=852

Increasing prevalence of chronic diseases globally is expected to serve to be a highly impacting factor for CT scanners market growth. Chronic diseases such as cardiovascular diseases and cancer are difficult to manage and causes significant cost burden on healthcare sector. Key to better management of these diseases is accurate diagnosis of conditions in early stages. As CT scanner allows the early and accurate diagnosis of several chronic diseases, its demand is forecasted to increase with the rising prevalence of chronic diseases.

CT scanner is a cost intensive capital equipment and its high cost is forecasted to hamper affordability, particularly in developing and underdeveloped region. Moreover, refurbished and used CT equipment are available at significant low cost compared to brand new equipment. Availability of such equipment will restrain industry growth to some extent.

Request to View Sample of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=852

Most of the key companies operating in the global CT scanners market are concentrating on development of portable products and expanding their geographical presence to strengthen their position in the global market. For instance, THE Jerudong Park Medical Centre (JPMC) has grabbed another landmark with introducing the latest Computed Tomography (CT) scanner which offers increased efficiency and clinical flexibility. It is one of the major developmental achievements for the company, the state-of-the-art machine with some of the latest technology and functions and capability of producing images of human body from X-ray test and computer. These new launches are expected to drive growth of the market due to increase in efficiency.

GE Healthcare, Medtronic PLC, Koninklijke Philips N.V., Siemens AG, Carestream Health, Inc., Hitachi Ltd, Accuray Incorporated, Koning Corporation, Neusoft Corporation, Samsung Electronics Co., Ltd., Planmed Oy, Toshiba Corporation, Shenzhen Anke High-Tech Co., Ltd., and Shimadzu Corporation are some of the key companies currently operating in the global CT scanners market. These companies are increasingly investing on the development of machines which is key factor boosting adoption of machines.

The global active pharmaceutical ingredients market was valued at US$ 162,000.0 Mn in 2017 and is projected to expand at a cumulative annual growth rate (CAGR) of 5.4% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled ‘Global Active Pharmaceutical Ingredients (API)- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2028.’ The report suggests that increase in the use of pharmaceuticals globally is estimated to boost the active pharmaceutical ingredients market between 2018 and 2026.

Increase in Government Prioritization of Biomedical Innovation Globally to Fuel Market

Governments across the world have prioritized biomedical innovation. Accelerated regulatory review by the FDA for innovative medicines boosts the global active pharmaceutical ingredients market. The FDA has approved more than 45 drugs in 2017. Drugs approved by the FDA are used for the treatment of relapsed or refractory acute lymphoblastic leukemia, relapsed breast cancer, moderate-to-severe plaque psoriasis, advanced or metastatic urothelial carcinoma, acute bacterial skin infections, Chagas disease, open-angle glaucoma or ocular hypertension, type 2 diabetes mellitus, and septic or other distributive shock.

Request to View Sample of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1690

Increase in the Incidence of Acute and Chronic Diseases Globally to Fuel Market

Rise in the prevalence of cancer, cardiovascular diseases, and diabetes; sedentary lifestyles; and a rise in the aging population are key factors driving the active pharmaceutical ingredients (API) market. As per the National Cancer Institute, in 2016, there were an estimated 15.5 million cancer survivors in the U.S.. The number of cancer survivors is expected to increase to 20.3 million by 2026. As per an EU government agency survey, almost 49 million people were living with cardiovascular disease in the EU in 2017. Lung cancer is the leading cause of cancer deaths in Asia Pacific. China alone accounts for more than 50% of all cancer cases in this region. Changes in lifestyle and socio-cultural factors are propelling the incidence of cervical cancer. Major countries affected by breast cancer in Asia Pacific are India, Thailand, and China.

The Dominant In-house API Manufacturing Segment is Estimated to Lose Market Share During the Forecast Period

The in-house API manufacturing segment includes the active pharmaceutical ingredients produced for the internal consumption of a pharmaceutical company. The revenue of the in-house API manufacturing segment has declined in the past few years due to outsourcing of API production. High degree of competition and reduced profitability are the key factors attributed to the increased preference for outsourcing API production over in-house API manufacturing.

Request PDF Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1690

Synthetic Chemical API Segment is Projected to Lead the Active Pharmaceutical Ingredients Market

Around 66.0% of the APIs currently available in the market constitute synthetic chemical APIs, popularly known as small molecules. Although the top-selling drugs are biologics, the number of these drugs is quite small as compared to the small molecule drugs. Currently, over 3,000 small molecule drugs are available in the market, which provides significant business opportunities for synthetic API production.

Anti-infective Drugs and Cardiovascular Drugs Lead the Market

In terms of therapeutic, the market has been categorized into anti-infective drugs, metabolic disorders drugs, cardiovascular drugs, oncology drugs, central nervous system drugs, respiratory diseases drugs and others. The anti-infective drugs segment is likely to account for a leading share of the market during the forecast period. Increase in the incidence of cardiovascular diseases is anticipated to fuel the cardiovascular drugs segment during the forecast period.